China Meheco Group Co., Ltd.

Shanghai Stock Exchange 600056.SS

China Meheco Group Co., Ltd. EBITDA for the year ending December 31, 2023: USD 320.23 M

China Meheco Group Co., Ltd. EBITDA is USD 320.23 M for the year ending December 31, 2023, a 25.66% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • China Meheco Group Co., Ltd. EBITDA for the year ending December 31, 2022 was USD 254.84 M, a 12.70% change year over year.
  • China Meheco Group Co., Ltd. EBITDA for the year ending December 31, 2021 was USD 226.13 M, a -37.10% change year over year.
  • China Meheco Group Co., Ltd. EBITDA for the year ending December 31, 2020 was USD 359.49 M, a 20.34% change year over year.
  • China Meheco Group Co., Ltd. EBITDA for the year ending December 31, 2019 was USD 298.72 M, a -23.03% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
Shanghai Stock Exchange: 600056.SS

China Meheco Group Co., Ltd.

CEO Ms. Huidong Hu
IPO Date May 15, 1997
Location China
Headquarters No. 18 Guangming Zhongjie
Employees 8,389
Sector Health Care
Industries
Description

China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company imports and exports China national medicines and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral drugs; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products and raw materials; chemical raw materials; and nutritional and other healthcare products. The company also plants, processes, warehouses, and transports ginseng, licorice, ephedra, rhubarb, rheum officinale, astragalus membranaceus, scutellaria baicalensis, fennel, and other herbs. China Meheco Group Co., Ltd. was founded in 1984 and is based in Beijing, China.

Similar companies

600007.SS

China World Trade Center Co., Ltd.

USD 3.20

0.78%

600061.SS

SDIC Capital Co.,Ltd

USD 0.96

3.09%

600038.SS

Avicopter Plc

USD 5.16

2.31%

600039.SS

Sichuan Road & Bridge Co.,Ltd

USD 0.98

1.14%

600062.SS

China Resources Double-Crane Pharmaceutical Co.,Ltd.

USD 2.64

2.39%

StockViz Staff

January 15, 2025

Any question? Send us an email